The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Breast cancer statistics, 2017, racial disparity in mortality by state
Open accessAbstract
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 252,710 new cases of invasive breast cancer and 40,610 breast cancer deaths are expected to occur among US women in 2017. From 2005 to 2014, overall breast cancer incidence rates increased among Asian/Pacific Islander (1.7% per year), non‐Hispanic black (NHB) (0.4% per year), and Hispanic (0.3% per year) women but were stable in non‐Hispanic white (NHW) and American Indian/Alaska Native (AI/AN) women. The increasing trends were driven by increases in hormone receptor‐positive breast cancer, which increased among all racial/ethnic groups, whereas rates of hormone receptor‐negative breast cancers decreased. From 1989 to 2015, breast cancer death rates decreased by 39%, which translates to 322,600 averted breast cancer deaths in the United States. During 2006 to 2015, death rates decreased in all racial/ethnic groups, including AI/ANs. However, NHB women continued to have higher breast cancer death rates than NHW women, with rates 39% higher (mortality rate ratio [MRR], 1.39; 95% confidence interval [CI], 1.35‐1.43) in NHB women in 2015, although the disparity has ceased to widen since 2011. By state, excess death rates in black women ranged from 20% in Nevada (MRR, 1.20; 95% CI, 1.01‐1.42) to 66% in Louisiana (MRR, 1.66; 95% CI, 1.54, 1.79). Notably, breast cancer death rates were not significantly different in NHB and NHW women in 7 states, perhaps reflecting an elimination of disparities and/or a lack of statistical power. Improving access to care for all populations could eliminate the racial disparity in breast cancer mortality and accelerate the reduction in deaths from this malignancy nationwide. CA Cancer J Clin 2017;67:439‐448. © 2017 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Self-citationSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
Self-citationEffect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Iqbal, J., Ginsburg, O., Rochon, P. A., Sun, P., & Narod, S. A. (2015) · JAMA · doi:10.1001/jama.2014.17322 · Cited by 614
Cancer Incidence and Mortality Trends Among Whites in the United States, 1947–84
(1987) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/79.4.701 · Cited by 450
Daly, B., & Olopade, O. I. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21271 · Cited by 327
Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review
Newman, L. A., & Kaljee, L. M. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.0005 · Cited by 304
Self-citationIncidence of Breast Cancer in the United States: Current and Future Trends
Anderson, W. F., Katki, H. A., & Rosenberg, P. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr257 · Cited by 285
Huo, D., Hu, H., Rhie, S. K., Gamazon, E. R., Cherniack, A. D., Liu, J., Yoshimatsu, T. F., Pitt, J. J., Hoadley, K. A., Troester, M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0595 · Cited by 283
Warner, E. T., Tamimi, R. M., Hughes, M. E., Ottesen, R. A., Wong, Y.-N., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1349 · Cited by 280
Established breast cancer risk factors and risk of intrinsic tumor subtypes
Barnard, M. E., Boeke, C. E., & Tamimi, R. M. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.002 · Cited by 278
How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?
Anderson, W. F., Rosenberg, P. S., Prat, A., Perou, C. M., & Sherman, M. E. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju165 · Cited by 265
Eliminating racial disparities in colorectal cancer in the real world: It took a village
Grubbs, S. S., Polite, B. N., Carney, J., Bowser, W., Rogers, J., Katurakes, N., Hess, P., & Paskett, E. D. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.8412 · Cited by 201
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
Cheang, M. C. U., Martin, M., Nielsen, T. O., Prat, A., Voduc, D., Rodriguez-Lescure, A., Ruiz, A., Chia, S., Shepherd, L., Ruiz-Borrego, M., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0372 · Cited by 194
Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
DeSantis, C., Howlader, N., Cronin, K. A., & Jemal, A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0061 · Cited by 159
Self-citationEffects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality
Muñoz, D. F., Near, A. M., van Ravesteyn, N. T., Lee, S. J., Schechter, C. B., Alagöz, O., Berry, D. A., Burnside, E. S., Chang, Y.-J., Chisholm, G. B., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju289 · Cited by 146
Tao, L., Gomez, S. L., Keegan, T. H. M., Kurian, A. W., & Clarke, C. A. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0243 · Cited by 138
The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999
Elkin, E. B., Hudis, C. A., Begg, C. B., & Schrag, D. (2005) · Cancer · doi:10.1002/cncr.21285 · Cited by 130
Trends in breast cancer incidence and mortality in the United States: implications for prevention
Toriola, A. T., & Colditz, G. A. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2500-7 · Cited by 113
Impact of Triple Negative Phenotype on Breast Cancer Prognosis
Kaplan, H. G., & Malmgren, J. A. (2008) · The Breast Journal · doi:10.1111/j.1524-4741.2008.00622.x · Cited by 110
Improvements in Health Status after Massachusetts Health Care Reform
van der Wees, P. J., Zaslavsky, A. M., & Ayanian, J. Z. (2013) · Milbank Quarterly · doi:10.1111/1468-0009.12029 · Cited by 107
Ma, H., Ursin, G., Xu, X., Lee, E., Togawa, K., Duan, L., Lu, Y., Malone, K. E., Marchbanks, P. A., McDonald, J. A., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-016-0799-9 · Cited by 96
Park, J., Anderson, W. F., & Gail, M. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.9191 · Cited by 73
Hunt, B. R., & Hurlbert, M. S. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.07.018 · Cited by 61
The impact of changes in hormone therapy on breast cancer incidence in the US population
Coombs, N. J., Cronin, K. A., Taylor, R. J., Freedman, A. N., & Boyages, J. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9437-5 · Cited by 54
Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California
Parise, C. A., & Caggiano, V. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.08.001 · Cited by 52
Sighoko, D., Murphy, A. M., Irizarry, B., Rauscher, G. H., Ferrans, C. E., & Ansell, D. A. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0878-y · Cited by 45
Rust, G. S., Zhang, S., Malhotra, K., Reese, L. E., McRoy, L., Baltrus, P., Caplan, L. S., & Levine, R. S. (2015) · Cancer · doi:10.1002/cncr.29405 · Cited by 35
Hines, L. M., Sedjo, R. L., Byers, T., John, E. M., Fejerman, L., Stern, M. C., Baumgartner, K. B., Giuliano, A. R., Torres-Mejı́a, G., Wolff, R. K., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0721 · Cited by 24
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Self-citationHarbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Epidemiological characteristics of and risk factors for breast cancer in the world
Momenimovahed, Z., & Salehiniya, H. (2019) · Breast Cancer: Targets and Therapy · doi:10.2147/bctt.s176070 · Cited by 1,050
Tripathy, D., Im, S.-A., Colleoni, M., Franke, F., Bardia, A., Harbeck, N., Hurvitz, S. A., Chow, L., Sohn, J., Lee, K. S., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30292-4 · Cited by 1,025
The role of m6A RNA methylation in cancer
Sun, T., Wu, R., & Ming, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108613 · Cited by 963
Metadata
- Authors
- DeSantis, C. E., Ma, J., Goding Sauer, A., Newman, L. A., & Jemal, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2017-10-03
- Volume
- 67
- Issue
- 6
- Pages
- 439-448
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2762481118
- Cited by
- 1,879
- References
- 32
- FWCI
- 91.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.